Does MEPOLIZUMAB Cause Injection site swelling? 138 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 138 reports of Injection site swelling have been filed in association with MEPOLIZUMAB (Nucala). This represents 0.3% of all adverse event reports for MEPOLIZUMAB.
138
Reports of Injection site swelling with MEPOLIZUMAB
0.3%
of all MEPOLIZUMAB reports
4
Deaths
36
Hospitalizations
How Dangerous Is Injection site swelling From MEPOLIZUMAB?
Of the 138 reports, 4 (2.9%) resulted in death, 36 (26.1%) required hospitalization, and 4 (2.9%) were considered life-threatening.
Is Injection site swelling Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MEPOLIZUMAB. However, 138 reports have been filed with the FAERS database.
What Other Side Effects Does MEPOLIZUMAB Cause?
Asthma (11,033)
Dyspnoea (9,192)
Wheezing (6,093)
Product dose omission issue (5,873)
Cough (4,577)
Pneumonia (4,107)
Therapeutic product effect incomplete (4,106)
Drug ineffective (3,880)
Loss of personal independence in daily activities (3,566)
Fatigue (2,656)
What Other Drugs Cause Injection site swelling?
ETANERCEPT (9,992)
DUPILUMAB (9,582)
ADALIMUMAB (4,428)
EVOLOCUMAB (1,933)
GLATIRAMER (1,836)
IXEKIZUMAB (1,615)
TIRZEPATIDE (1,131)
ENBREL (1,121)
HYDROXYPROGESTERONE CAPROATE (924)
HUMIRA (838)
Which MEPOLIZUMAB Alternatives Have Lower Injection site swelling Risk?
MEPOLIZUMAB vs MEPROBAMATE
MEPOLIZUMAB vs MERCAPTOPURINE
MEPOLIZUMAB vs MEROPENEM
MEPOLIZUMAB vs MEROPENEM ANHYDROUS
MEPOLIZUMAB vs MESALAMINE